Literature DB >> 11228100

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma.

D Ribatti1, G Surico, A Vacca, F De Leonardis, G Lastilla, P G Montaldo, N Rigillo, M Ponzoni.   

Abstract

In human tumors changes in angiogenesis and expression of extracellular matrix-degrading enzymes occur simultaneously during invasion and metastasis. Tissues from 20 biopsies of human neuroblastoma (NB) were investigated immunohistochemically by using an antibody against factor VIII to determine their microvessel number, and by in situ hybridisation to determine the expression of mRNA of the matrix metalloproteinase-2 (MMP-2) and MMP-9. The extent of angiogenesis and the expression of the MMP-2 and MMP-9 mRNA were upregulated in advancing stages. These in situ data suggest that angiogenesis and degradation of extracellular matrix occur simultaneously with NB tumor progression.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11228100     DOI： 10.1016/s0024-3205(00)01030-4

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


  14 in total

1.  Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.

Authors:  Zhong-Sheng Zhao; Ji-Lin Zhou; Gen-You Yao; Guo-Qing Ru; Jie Ma; Jun Ruan
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

2.  Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.

Authors:  Shakeel Modak; Brian H Kushner; Ellen Basu; Stephen S Roberts; Nai-Kong V Cheung
Journal:  Pediatr Blood Cancer       Date:  2017-01-23       Impact factor: 3.167

3.  Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells.

Authors:  Unmesh Jadhav; Sanjeeva Mohanam
Journal:  Int J Oncol       Date:  2006-12       Impact factor: 5.650

4.  Tissue inhibitor of metalloproteinase-3 via oncolytic herpesvirus inhibits tumor growth and vascular progenitors.

Authors:  Yonatan Y Mahller; Sachin S Vaikunth; Maria C Ripberger; William H Baird; Yoshinaga Saeki; Jose A Cancelas; Timothy M Crombleholme; Timothy P Cripe
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

5.  Generation and characterization of novel local and metastatic human neuroblastoma variants.

Authors:  Ido Nevo; Orit Sagi-Assif; Liat Edry Botzer; Dana Amar; Shelly Maman; Naam Kariv; Leonor E Leider-Trejo; Larissa Savelyeva; Manfred Schwab; Ilana Yron; Isaac P Witz
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

6.  Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release.

Authors:  Damien Destouches; Eric Huet; Maha Sader; Sophie Frechault; Gilles Carpentier; Florie Ayoul; Jean-Paul Briand; Suzanne Menashi; José Courty
Journal:  J Biol Chem       Date:  2012-10-29       Impact factor: 5.157

7.  Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex).

Authors:  Nataly Tarasenko; Abraham Nudelman; Igor Tarasenko; Michal Entin-Meer; Daphne Hass-Kogan; Aida Inbal; Ada Rephaeli
Journal:  Clin Exp Metastasis       Date:  2008-05-28       Impact factor: 5.150

8.  Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma.

Authors:  Louis Chesler; David D Goldenberg; Isha T Seales; Ronit Satchi-Fainaro; Matt Grimmer; Rodney Collins; Chris Struett; Kim N Nguyen; Grace Kim; Tarik Tihan; Yun Bao; Rolf A Brekken; Gabriele Bergers; Judah Folkman; William A Weiss
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 9.  Herpes simplex virus oncolytic therapy for pediatric malignancies.

Authors:  Gregory K Friedman; Joseph G Pressey; Alyssa T Reddy; James M Markert; G Yancey Gillespie
Journal:  Mol Ther       Date:  2009-04-14       Impact factor: 11.454

10.  Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

Authors:  Martin Michaelis; Denise Klassert; Susanne Barth; Tatyana Suhan; Rainer Breitling; Bernd Mayer; Nora Hinsch; Hans W Doerr; Jaroslav Cinatl; Jindrich Cinatl
Journal:  Mol Cancer       Date:  2009-09-29       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.